Dr. Nicholas Ialongo, a professor in the department of mental health at the Johns Hopkins Bloomberg School of Public Health, received a $2.25 million, five-year grant from the National Institute of Drug Abuse (NIDA) to study development and malleability from childhood to adulthood. The study will look at the normal and pathogenic development of two preventive interventions, extended through ages 31-35, on various targets such as antisocial behavior, substance abuse/dependence, and more.
Dr. Ialongo and his team will continue to study the impacts of a prospective, developmental epidemiological prevention trial that involves a population of urban, predominantly African American young adults, who began first grade in fall of 1993 in nine elementary schools in Baltimore. The study, which has been ongoing since 1993, has collected data on each participant, family, peer group and school, to determine if two interventions used – the Family School Partnership and Classroom-Centered – successfully targeted aggressive-coercive behavior and poor academic achievement to prevent future outcomes like antisocial behavior, substance abuse, and other outcomes.
This $2.25 million grant will allow Dr. Ialongo to conduct a more precise assessment of the timing and sequencing of the interplay of phenotypic and genetic influences, including the interventions, on successful adaptation to the relevant developmental challenges between the ages of 31-35. He and his team will also continue to study the role of phenotypic and genetic factors and the impact the interventions had on adulthood outcomes. The study’s outcomes will help inform the nature, targets and timing of future preventive intervention efforts.
Dr. Ialongo’s work focuses on evaluating promising, early elementary school-based strategies to improve student academic, behavioral, and socioemotional outcomes and to prevent mental and substance abuse disorders.